— Know what they know.
Not Investment Advice

PGNY NASDAQ

Progyny, Inc.
1W: +8.0% 1M: +37.2% 3M: +17.7% YTD: -4.1% 1Y: +12.9% 3Y: -31.3% 5Y: -51.1%
$24.88
+0.19 (+0.77%)
 
Weekly Expected Move ±12.8%
$17 $20 $23 $26 $29
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Buy · Power 70 · $1.9B mcap · 72M float · 2.28% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
53.3 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 26.9%  ·  5Y Avg: 6.7%
Cost Advantage ★
81
Intangibles
36
Switching Cost
47
Network Effect
57
Scale
52
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. PGNY shows a Weak competitive edge (53.3/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 26.9% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$27
Low
$28
Avg Target
$30
High
Based on 2 analysts since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 15Hold: 5Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$28.75
Analysts4
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-19 Canaccord Genuity $23 $30 +7 +24.7% $24.05
2026-05-15 Barclays $29 $27 -2 +16.1% $23.25
2026-03-06 Jefferies Brian Tanquilut $19 $30 +11 +68.7% $17.79
2026-03-02 Truist Financial Jailendra Singh $34 $28 -6 +58.3% $17.69
2026-01-21 J.P. Morgan Initiated $35 +38.4% $25.28
2026-01-08 Truist Financial Jailendra Singh $27 $34 +7 +20.4% $28.23
2026-01-08 KeyBanc Scott Schoenhaus $30 $32 +2 +19.4% $26.80
2025-12-08 Barclays Peter Warendorf Initiated $29 +17.4% $24.70
2025-11-11 KeyBanc Initiated $30 +26.0% $23.81
2025-08-08 Raymond James Sarah James Initiated $28 +26.0% $22.22
2025-07-17 Truist Financial Jailendra Singh $19 $27 +8 +17.1% $23.05
2025-02-28 Canaccord Genuity $18 $23 +5 +2.1% $22.53
2024-11-13 Jefferies Glen Santangelo $24 $19 -5 -12.1% $21.61
2024-11-13 Cantor Fitzgerald Sarah James Initiated $22 +1.8% $21.61
2024-11-13 Truist Financial Jailendra Singh $33 $19 -14 -12.1% $21.61
2024-09-20 Canaccord Genuity Richard Close $24 $18 -6 +9.4% $16.46
2024-09-20 Bank of America Securities Michael Cherny Initiated $22 +33.7% $16.46
2024-09-19 Jefferies Glen Santangelo Initiated $24 +45.0% $16.55
2024-09-19 Truist Financial Jailendra Singh $37 $33 -4 +85.6% $17.78
2024-08-06 Canaccord Genuity Richard Close Initiated $24 -6.8% $25.74
2024-07-16 JMP Securities Constantine Davides Initiated $36 +24.0% $29.03
2024-05-17 Truist Financial Jailendra Singh Initiated $37 +34.3% $27.55
2024-05-10 BTIG David Larsen Initiated $41 +26.2% $32.50

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
3
ROE
4
ROA
5
D/E
3
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. PGNY receives an overall rating of B+. Strongest factors: ROE (4/5), ROA (5/5). Areas of concern: P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-11 A- B+
2026-05-08 B+ A-
2026-03-04 B B+
2026-02-26 B+ B
2026-02-09 B B+
2026-02-02 B+ B
2026-01-26 B B+
2026-01-15 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

69 Grade A
Profitability
42
Balance Sheet
97
Earnings Quality
43
Growth
62
Value
54
Momentum
89
Safety
100
Cash Flow
72
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. PGNY scores highest in Safety (100/100) and lowest in Profitability (42/100). An overall grade of A places PGNY among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.97
Safe Zone
Piotroski F-Score
7/9
Beneish M-Score
-3.33
Unlikely Manipulator
Ohlson O-Score
-10.36
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 94.4/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 3.00x
Accruals: -20.1%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PGNY scores 6.97, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PGNY scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. PGNY's score of -3.33 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PGNY's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PGNY receives an estimated rating of AA+ (score: 94.4/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). PGNY's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
29.74x
PEG
0.85x
P/S
1.51x
P/B
4.58x
P/FCF
7.94x
P/OCF
7.08x
EV/EBITDA
10.67x
EV/Revenue
0.89x
EV/EBIT
11.06x
EV/FCF
6.36x
Earnings Yield
4.70%
FCF Yield
12.60%
Shareholder Yield
13.92%
Graham Number
$10.46
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 29.7x earnings, PGNY commands a growth premium. Graham's intrinsic value formula yields $10.46 per share, 138% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.640
NI / EBT
×
Interest Burden
1.014
EBT / EBIT
×
EBIT Margin
0.081
EBIT / Rev
×
Asset Turnover
1.916
Rev / Assets
×
Equity Multiplier
1.439
Assets / Equity
=
ROE
14.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PGNY's ROE of 14.4% is driven by Asset Turnover (1.916), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
22.93%
Fair P/E
54.36x
Intrinsic Value
$43.42
Price/Value
0.39x
Margin of Safety
60.89%
Premium
-60.89%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with PGNY's realized 22.9% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $43.42, PGNY appears undervalued with a 61% margin of safety. The adjusted fair P/E of 54.4x compares to the current market P/E of 29.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1652 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$24.88
Median 1Y
$22.01
5th Pctile
$7.51
95th Pctile
$64.65
Ann. Volatility
61.9%
Analyst Target
$28.75
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Peter Anevski
Chief Executive Officer
$870,000 $3,499,980 $7,220,612
Melissa Cummings Operating
rating Officer
$429,546 $1,149,993 $2,695,161
Mark Livingston Financial
ancial Officer
$533,000 $999,988 $2,480,374
Geoffrey Clapp Product
roduct Officer
$336,458 $749,979 $1,772,628
Allison Swartz EVP,
General Counsel and Secretary
$409,500 $624,976 $1,645,151

CEO Pay Ratio

28:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,220,612
Avg Employee Cost (SGA/emp): $256,083
Employees: 856

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
856
+25.9% YoY
Revenue / Employee
$1,505,445
Rev: $1,288,661,000
Profit / Employee
$68,364
NI: $58,520,000
SGA / Employee
$256,083
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 55.2% 63.7% 31.4% 26.5% 21.8% 20.1% 9.7% 13.7% 15.7% 16.5% 13.3% 13.2% 13.5% 12.3% 11.1% 10.8% 10.9% 11.6% 12.5% 14.4% 14.43%
ROA 38.4% 44.3% 21.5% 18.2% 14.9% 13.7% 6.7% 9.6% 10.9% 11.5% 9.5% 9.4% 9.7% 8.8% 8.0% 7.7% 7.8% 8.3% 8.7% 10.0% 10.03%
ROIC 1.1% 1.3% 46.5% 39.4% 32.7% 29.7% 14.8% 20.7% 23.0% 23.5% 27.1% 25.9% 26.1% 22.7% 20.6% 20.6% 21.4% 23.9% 22.7% 26.9% 26.85%
ROCE 16.6% 19.0% 12.5% 7.9% 6.8% 7.7% 6.1% 10.0% 11.7% 13.5% 10.9% 11.5% 12.5% 11.5% 15.4% 16.7% 18.1% 20.8% 17.2% 19.3% 19.31%
Gross Margin 23.0% 23.3% 19.7% 19.1% 22.5% 22.4% 20.8% 22.7% 21.7% 22.3% 21.1% 22.4% 22.5% 20.7% 21.3% 23.4% 23.7% 23.2% 24.1% 25.3% 25.29%
Operating Margin 9.1% 7.4% -0.1% -0.0% 4.5% 5.5% 1.5% 5.8% 5.4% 6.5% 5.1% 6.7% 6.8% 4.3% 5.3% 7.5% 7.3% 6.9% 4.8% 10.8% 10.77%
Net Margin 14.6% 13.7% 11.8% 2.9% 4.5% 6.4% 1.6% 6.8% 5.4% 5.7% 5.0% 6.1% 5.4% 3.6% 3.5% 4.6% 5.1% 4.4% 3.9% 7.4% 7.38%
EBITDA Margin 9.3% 7.6% 0.1% 0.2% 4.7% 5.7% 1.8% 6.0% 5.6% 6.7% 5.3% 6.9% 7.1% 4.6% 5.6% 7.8% 8.5% 8.1% 6.0% 10.8% 10.77%
FCF Margin 3.1% 4.7% 4.8% 2.1% 6.2% 4.9% 9.8% 12.5% 17.3% 19.3% 17.0% 17.2% 15.1% 14.1% 14.9% 16.1% 15.3% 15.0% 14.6% 14.0% 14.02%
OCF Margin 3.3% 5.0% 5.2% 2.6% 6.6% 5.4% 10.2% 12.9% 17.7% 19.6% 17.3% 17.5% 15.4% 14.5% 15.3% 16.7% 16.3% 16.2% 16.1% 15.7% 15.72%
ROE 3Y Avg snapshot only 12.21%
ROE 5Y Avg snapshot only 14.02%
ROA 3Y Avg snapshot only 8.62%
ROIC 3Y Avg snapshot only 22.65%
ROIC Economic snapshot only 12.01%
Cash ROA snapshot only 27.38%
Cash ROIC snapshot only 88.39%
CROIC snapshot only 78.86%
NOPAT Margin snapshot only 4.77%
Pretax Margin snapshot only 8.18%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 16.65%
SBC / Revenue snapshot only 2.50%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 75.91 62.77 76.80 92.43 63.48 88.02 102.67 74.71 80.31 66.03 60.38 62.93 44.61 27.45 30.30 38.00 37.12 34.33 39.26 21.26 29.742
P/S Ratio 13.09 11.87 10.09 9.33 4.69 5.28 3.96 3.68 4.13 3.32 3.44 3.48 2.47 1.38 1.41 1.64 1.59 1.53 1.78 1.11 1.507
P/B Ratio 35.27 33.67 20.06 20.40 11.50 14.69 8.27 8.53 10.50 9.10 6.77 6.97 5.06 2.84 3.90 4.73 4.67 4.60 4.45 2.79 4.583
P/FCF 424.26 253.82 211.28 439.30 75.50 107.04 40.40 29.54 23.93 17.25 20.23 20.25 16.38 9.80 9.48 10.19 10.37 10.20 12.18 7.94 7.937
P/OCF 394.55 236.57 194.00 360.65 70.69 98.14 38.77 28.57 23.37 16.93 19.84 19.91 16.06 9.55 9.19 9.82 9.76 9.47 11.09 7.08 7.081
EV/EBITDA 187.45 158.08 146.86 231.42 146.64 168.33 117.68 75.54 80.91 60.43 52.65 51.41 33.13 17.84 20.36 23.30 21.12 18.16 20.52 10.67 10.665
EV/Revenue 12.86 11.66 9.87 9.13 4.51 5.13 3.73 3.48 3.94 3.15 3.12 3.16 2.16 1.07 1.23 1.47 1.42 1.37 1.56 0.89 0.892
EV/EBIT 197.99 164.92 152.76 245.47 157.71 180.81 125.76 79.04 84.38 62.88 54.58 53.33 34.38 18.65 21.31 24.44 22.18 19.04 21.61 11.06 11.058
EV/FCF 417.07 249.31 206.64 429.82 72.61 103.83 38.04 27.87 22.83 16.33 18.33 18.41 14.32 7.61 8.28 9.12 9.27 9.10 10.66 6.36 6.359
Earnings Yield 1.3% 1.6% 1.3% 1.1% 1.6% 1.1% 1.0% 1.3% 1.2% 1.5% 1.7% 1.6% 2.2% 3.6% 3.3% 2.6% 2.7% 2.9% 2.5% 4.7% 4.70%
FCF Yield 0.2% 0.4% 0.5% 0.2% 1.3% 0.9% 2.5% 3.4% 4.2% 5.8% 4.9% 4.9% 6.1% 10.2% 10.5% 9.8% 9.6% 9.8% 8.2% 12.6% 12.60%
PEG Ratio snapshot only 0.850
Price/Tangible Book snapshot only 2.938
EV/OCF snapshot only 5.673
EV/Gross Profit snapshot only 3.699
Acquirers Multiple snapshot only 11.950
Shareholder Yield snapshot only 13.92%
Graham Number snapshot only $10.46
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.45 2.45 2.62 2.62 2.62 2.62 2.72 2.72 2.72 2.72 3.44 3.44 3.44 3.44 2.80 2.80 2.80 2.80 2.73 2.73 2.726
Quick Ratio 2.45 2.45 2.62 2.62 2.62 2.62 2.72 2.72 2.72 2.72 3.44 3.44 3.44 3.44 2.80 2.80 2.80 2.80 2.73 2.73 2.726
Debt/Equity 0.06 0.06 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.02 0.04 0.04 0.04 0.04 0.05 0.05 0.05 0.05 0.05 0.05 0.047
Net Debt/Equity -0.60 -0.60 -0.44 -0.44 -0.44 -0.44 -0.48 -0.48 -0.48 -0.48 -0.64 -0.64 -0.64 -0.64 -0.49 -0.49 -0.49 -0.49 -0.55 -0.55 -0.554
Debt/Assets 0.04 0.04 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.01 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.032
Debt/EBITDA 0.31 0.27 0.26 0.40 0.46 0.41 0.31 0.19 0.17 0.14 0.30 0.28 0.26 0.28 0.27 0.25 0.23 0.20 0.24 0.22 0.222
Net Debt/EBITDA -3.23 -2.86 -3.29 -5.10 -5.83 -5.20 -7.28 -4.52 -3.89 -3.38 -5.46 -5.16 -4.76 -5.14 -2.95 -2.72 -2.50 -2.19 -2.92 -2.65 -2.646
Interest Coverage 562.29 956.46 1796.67
Equity Multiplier 1.52 1.52 1.42 1.42 1.42 1.42 1.44 1.44 1.44 1.44 1.37 1.37 1.37 1.37 1.44 1.44 1.44 1.44 1.44 1.44 1.439
Cash Ratio snapshot only 1.532
Cash to Debt snapshot only 12.921
FCF to Debt snapshot only 7.556
Defensive Interval snapshot only 899.3 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 2.23 2.34 1.64 1.80 2.02 2.29 1.75 1.94 2.13 2.29 1.68 1.71 1.74 1.75 1.71 1.78 1.82 1.86 1.91 1.92 1.916
Inventory Turnover
Receivables Turnover 7.33 7.71 4.76 5.24 5.87 6.66 4.20 4.66 5.11 5.51 4.52 4.60 4.70 4.73 4.89 5.08 5.21 5.32 5.66 5.68 5.676
Payables Turnover 11.13 11.63 7.41 8.28 9.28 10.53 7.26 7.97 8.76 9.45 7.24 7.38 7.52 7.60 8.29 8.58 8.75 8.87 8.98 8.96 8.955
DSO 50 47 77 70 62 55 87 78 71 66 81 79 78 77 75 72 70 69 65 64 64.3 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 33 31 49 44 39 35 50 46 42 39 50 49 49 48 44 43 42 41 41 41 40.8 days
Cash Conversion Cycle 17 16 27 26 23 20 37 33 30 28 30 30 29 29 31 29 28 27 24 24 23.5 days
Fixed Asset Turnover snapshot only 23.547
Cash Velocity snapshot only 4.170
Capital Intensity snapshot only 0.574
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 1.1% 52.9% 45.2% 42.7% 37.1% 47.9% 57.2% 58.5% 55.2% 47.5% 38.3% 26.9% 18.3% 10.2% 7.2% 9.5% 9.6% 11.4% 10.4% 6.6% 6.59%
Net Income 43.3% 29.0% 42.2% -3.8% -41.2% -53.1% -53.8% -22.5% 8.1% 23.7% 1.0% 42.2% 27.3% 10.2% -12.4% -14.3% -15.3% -1.2% 7.7% 28.9% 28.95%
EPS 37.1% 28.6% 40.4% -3.7% -41.1% -52.8% -53.7% -22.7% 7.0% 22.4% 1.0% 41.0% 30.9% 18.5% -7.6% -3.0% -7.6% 2.7% 14.9% 35.9% 35.87%
FCF 1.4% 5.7% -32.0% -51.0% 1.8% 56.1% 2.2% 8.3% 3.3% 4.8% 1.4% 74.8% 3.3% -19.4% -6.2% 2.9% 11.3% 18.7% 8.6% -7.4% -7.38%
EBITDA 5.1% 2.4% 2.4% 18.6% -38.5% -39.0% -25.9% 85.0% 1.5% 1.5% 1.6% 69.6% 58.3% 27.2% 9.6% 12.5% 13.0% 39.5% 38.8% 41.0% 41.01%
Op. Income 7.3% 3.0% 3.0% 24.0% -39.6% -40.7% -27.8% 87.6% 1.5% 1.6% 1.7% 71.0% 59.1% 26.7% 8.5% 11.3% 7.8% 31.1% 26.4% 32.0% 31.99%
OCF Growth snapshot only 0.03%
Asset Growth snapshot only 22.29%
Equity Growth snapshot only 22.27%
Debt Growth snapshot only 24.53%
Shares Change snapshot only -5.10%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 1.3% 81.5% 65.6% 49.4% 46.7% 42.1% 36.0% 34.0% 32.6% 30.1% 26.3% 21.9% 17.9% 14.0% 13.99%
Revenue 5Y 78.1% 52.7% 42.6% 32.6% 30.2% 27.4% 27.36%
EPS 3Y 1.6% 9.7% 1.6% -6.2% -11.9% -4.6% 1.9% 9.0% 14.2% 29.2% 22.9% 22.93%
EPS 5Y 83.4% 7.0% 6.7% 6.71%
Net Income 3Y 1.6% 10.3% 2.0% -6.8% -13.8% -6.2% -1.9% 5.2% 10.4% 24.5% 16.3% 16.27%
Net Income 5Y 80.1% 4.8% 3.2% 3.22%
EBITDA 3Y 1.5% 92.5% 1.1% 73.4% 85.9% 55.0% 33.7% 25.1% 28.0% 52.3% 63.8% 64.8% 57.8% 39.1% 39.08%
EBITDA 5Y 1.1% 68.6% 75.5% 56.1% 57.7% 42.6% 42.63%
Gross Profit 3Y 1.4% 89.5% 73.3% 54.7% 50.5% 43.3% 35.7% 31.8% 31.2% 31.9% 28.6% 25.3% 22.1% 17.3% 17.33%
Gross Profit 5Y 84.8% 56.5% 47.1% 36.6% 34.2% 30.5% 30.50%
Op. Income 3Y 1.7% 1.0% 1.3% 83.8% 97.0% 58.5% 34.5% 25.1% 27.8% 52.8% 63.2% 62.9% 54.0% 35.9% 35.94%
Op. Income 5Y 1.3% 74.1% 85.4% 59.4% 60.0% 42.3% 42.34%
FCF 3Y 2.1% 2.1% 1.1% 74.0% 99.8% 1.3% 93.5% 93.7% 1.6% 70.5% 76.6% 34.7% 18.5% 18.52%
FCF 5Y 1.2% 1.0% 55.5% 39.9% 50.0% 50.00%
OCF 3Y 1.6% 1.7% 1.0% 73.4% 98.9% 1.3% 90.6% 90.2% 1.4% 70.2% 75.9% 37.1% 21.8% 21.75%
OCF 5Y 98.2% 86.9% 53.4% 41.7% 52.6% 52.56%
Assets 3Y 53.4% 53.4% 53.4% 53.4% 43.9% 43.9% 43.9% 43.9% 19.2% 19.2% 19.2% 19.2% 11.0% 11.0% 10.99%
Assets 5Y 32.2% 32.2% 32.2% 32.2% 23.9% 23.9% 23.93%
Equity 3Y 48.9% 48.9% 48.9% 48.9% 49.1% 49.1% 49.1% 49.1% 18.8% 18.8% 18.8% 18.8% 11.0% 11.0% 11.04%
Book Value 3Y 28.4% 48.6% 40.9% 47.9% 48.2% 48.6% 50.1% 52.5% 20.8% 23.3% 23.1% 22.9% 15.3% 17.4% 17.39%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.97 0.99 0.99 0.99 0.99 0.98 0.98 0.98 0.98 0.99 0.98 0.97 0.98 0.98 0.98 0.97 0.96 0.95 0.954
Earnings Stability 0.94 0.72 0.35 0.20 0.29 0.38 0.23 0.13 0.42 0.46 0.28 0.13 0.39 0.37 0.22 0.12 0.06 0.14 0.141
Margin Stability 0.89 0.95 0.92 0.93 0.91 0.95 0.93 0.94 0.96 0.98 0.98 0.97 0.92 0.95 0.94 0.95 0.94 0.95 0.952
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.91 0.97 0.91 0.50 0.83 0.89 0.96 0.95 0.94 0.94 1.00 0.97 0.88 0.884
Earnings Smoothness 0.00 0.65 0.96 0.48 0.28 0.26 0.75 0.92 0.79 0.31 0.65 0.76 0.90 0.87 0.85 0.83 0.99 0.93 0.75 0.747
ROE Trend 0.14 0.05 -0.04 -0.11 -0.19 -0.17 -0.19 -0.21 -0.06 -0.06 -0.04 -0.05 0.03 0.01 0.00 0.01 -0.01 0.01 0.014
Gross Margin Trend 0.03 0.01 0.00 -0.00 -0.00 0.01 0.00 -0.00 0.00 0.00 0.01 0.00 0.00 -0.00 0.00 0.01 0.02 0.02 0.022
FCF Margin Trend 0.06 -0.02 0.03 -0.01 0.02 0.08 0.13 0.14 0.10 0.10 0.03 0.02 0.01 0.01 -0.01 -0.02 -0.01 -0.03 -0.026
Sustainable Growth Rate 55.2% 63.7% 31.4% 26.5% 21.8% 20.1% 9.7% 13.7% 15.7% 16.5% 13.3% 13.2% 13.5% 12.3% 11.1% 10.8% 10.9% 11.6% 12.5% 14.4% 14.43%
Internal Growth Rate 62.3% 79.5% 27.4% 22.2% 17.5% 15.9% 7.2% 10.6% 12.3% 13.0% 10.6% 10.4% 10.7% 9.7% 8.7% 8.3% 8.4% 9.0% 9.5% 11.2% 11.15%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.19 0.27 0.40 0.26 0.90 0.90 2.65 2.62 3.44 3.90 3.04 3.16 2.78 2.87 3.30 3.87 3.80 3.63 3.54 3.00 3.002
FCF/OCF 0.93 0.93 0.92 0.82 0.94 0.92 0.96 0.97 0.98 0.98 0.98 0.98 0.98 0.97 0.97 0.96 0.94 0.93 0.91 0.89 0.892
FCF/Net Income snapshot only 2.679
OCF/EBITDA snapshot only 1.880
CapEx/Revenue 0.2% 0.3% 0.4% 0.5% 0.4% 0.4% 0.4% 0.4% 0.4% 0.4% 0.3% 0.3% 0.3% 0.4% 0.5% 0.6% 1.0% 1.2% 1.4% 1.7% 1.69%
CapEx/Depreciation snapshot only 5.707
Accruals Ratio 0.31 0.33 0.13 0.14 0.02 0.01 -0.11 -0.15 -0.27 -0.33 -0.20 -0.20 -0.17 -0.17 -0.18 -0.22 -0.22 -0.22 -0.22 -0.20 -0.201
Sloan Accruals snapshot only 0.061
Cash Flow Adequacy snapshot only 9.275
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Total Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 38.8% 2.9% 4.3% 5.5% 5.3% 2.2% 97.4% 1.4% 3.0% 2.96%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.6% 6.6% 15.6% 18.2% 13.9% 5.9% 2.8% 3.6% 13.9% 13.92%
Net Buyback Yield -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% 0.5% 6.5% 15.5% 18.2% 13.8% 5.9% 2.8% 3.5% 13.8% 13.83%
Total Shareholder Return -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% -0.1% 0.5% 6.5% 15.5% 18.2% 13.8% 5.9% 2.8% 3.5% 13.8% 13.83%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 2.63 2.65 2.03 2.71 2.61 2.11 1.24 1.05 1.00 0.89 0.88 0.80 0.74 0.70 0.65 0.60 0.60 0.59 0.61 0.64 0.640
Interest Burden (EBT/EBIT) 1.01 1.01 1.00 1.00 0.99 1.00 1.05 1.07 1.10 1.13 1.14 1.17 1.19 1.25 1.23 1.19 1.12 1.05 1.03 1.01 1.014
EBIT Margin 0.06 0.07 0.06 0.04 0.03 0.03 0.03 0.04 0.05 0.05 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.07 0.07 0.08 0.081
Asset Turnover 2.23 2.34 1.64 1.80 2.02 2.29 1.75 1.94 2.13 2.29 1.68 1.71 1.74 1.75 1.71 1.78 1.82 1.86 1.91 1.92 1.916
Equity Multiplier 1.44 1.44 1.46 1.46 1.46 1.46 1.43 1.43 1.43 1.43 1.40 1.40 1.40 1.40 1.40 1.40 1.40 1.40 1.44 1.44 1.439
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $0.78 $0.89 $0.66 $0.56 $0.46 $0.42 $0.30 $0.43 $0.49 $0.52 $0.62 $0.61 $0.64 $0.61 $0.57 $0.59 $0.59 $0.63 $0.65 $0.80 $0.80
Book Value/Share $1.67 $1.66 $2.51 $2.52 $2.53 $2.52 $3.77 $3.76 $3.75 $3.74 $5.49 $5.48 $5.66 $5.90 $4.42 $4.73 $4.71 $4.68 $5.77 $6.09 $5.43
Tangible Book/Share $1.54 $1.53 $2.39 $2.39 $2.40 $2.40 $3.65 $3.64 $3.63 $3.62 $5.38 $5.36 $5.54 $5.77 $4.25 $4.54 $4.52 $4.49 $5.48 $5.78 $5.78
Revenue/Share $4.51 $4.72 $4.99 $5.51 $6.19 $7.01 $7.86 $8.72 $9.52 $10.24 $10.81 $10.97 $11.58 $12.14 $12.23 $13.58 $13.86 $14.06 $14.40 $15.26 $15.98
FCF/Share $0.14 $0.22 $0.24 $0.12 $0.38 $0.35 $0.77 $1.09 $1.64 $1.97 $1.84 $1.88 $1.75 $1.71 $1.82 $2.19 $2.12 $2.11 $2.11 $2.14 $2.24
OCF/Share $0.15 $0.24 $0.26 $0.14 $0.41 $0.38 $0.80 $1.12 $1.68 $2.01 $1.87 $1.92 $1.78 $1.75 $1.88 $2.28 $2.25 $2.27 $2.31 $2.40 $2.51
Cash/Share $1.10 $1.09 $1.19 $1.19 $1.20 $1.20 $1.89 $1.89 $1.88 $1.88 $3.68 $3.67 $3.79 $3.96 $2.39 $2.55 $2.54 $2.53 $3.47 $3.66 $2.79
EBITDA/Share $0.31 $0.35 $0.34 $0.22 $0.19 $0.21 $0.25 $0.40 $0.46 $0.53 $0.64 $0.67 $0.76 $0.73 $0.74 $0.86 $0.93 $1.06 $1.10 $1.28 $1.28
Debt/Share $0.10 $0.10 $0.09 $0.09 $0.09 $0.09 $0.08 $0.08 $0.08 $0.08 $0.19 $0.19 $0.20 $0.21 $0.20 $0.22 $0.21 $0.21 $0.27 $0.28 $0.28
Net Debt/Share $-1.00 $-0.99 $-1.10 $-1.11 $-1.11 $-1.11 $-1.81 $-1.81 $-1.80 $-1.80 $-3.49 $-3.48 $-3.59 $-3.75 $-2.19 $-2.34 $-2.33 $-2.31 $-3.20 $-3.38 $-3.38
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 6.967
Altman Z-Prime snapshot only 11.596
Piotroski F-Score 6 6 6 6 6 6 8 7 6 6 8 7 8 6 6 6 6 7 6 7 7
Beneish M-Score -0.11 -0.27 -1.16 -1.10 -1.66 -1.58 -2.27 -2.53 -2.87 -3.16 -3.23 -3.31 -3.21 -3.14 -3.35 -3.56 -3.57 -3.59 -3.49 -3.33 -3.333
Ohlson O-Score snapshot only -10.364
ROIC (Greenblatt) snapshot only 25.79%
Net-Net WC snapshot only $3.84
EVA snapshot only $38751752.19
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA+
Credit Score 96.43 96.49 96.68 93.64 93.87 93.50 93.84 93.02 93.41 93.15 93.33 92.76 93.18 92.97 93.18 92.99 93.06 93.01 94.30 94.41 94.406
Credit Grade snapshot only 2
Credit Trend snapshot only 1.414
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 94
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms